[Summary] Large-scale pharmaceutical distribution enterprise
China Resources Pharmaceutical Group Limited (stock code: 03320.HK on the Hong Kong Stock Exchange) is a leading comprehensive pharmaceutical company in China, with business covering industrial manufacturing and commercial distribution of pharmaceuticals, health products, and medical devices. Since its listing, we have been included in several major capital market indices, including: Hang Seng Composite MidCap Index, Hang Seng Stock Connect Hong Kong Index, Hang Seng China State-Owned Enterprises Index, Hang Seng Stock Connect China State-Owned Enterprises ESG 40 Index, FTSE Global Equity Index Series, and MSCI China Index, among others.
Our subsidiaries include China Resources Pharmaceutical Commercial Group Co., Ltd., China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ), China Resources Double-Crane Pharmaceutical Co., Ltd. (600062.SH), China Resources Jiangzhong Pharmaceutical Group Co., Ltd. (Jiangzhong Pharmaceutical 600750.SH), Dong-E-E-Jiao Co., Ltd. (000423.SZ), China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ), China Resources Biomedical Pharmaceutical Co., Ltd., Sichuan Nigale Biomedical Technology Co., Ltd., and China Pharmaceutical Research and Development Center Co., Ltd., among others.
In 2024, China Resources Pharmaceutical achieved revenue of RMB 257.67 billion and net profit of RMB 8.40 billion.
The company manufactures 840 products, with a product portfolio including chemical drugs, traditional Chinese medicines, biological preparations, health products, and medical devices, covering a wide range of therapeutic areas, including cardiovascular, gastrointestinal and metabolic diseases, large-volume intravenous infusions, pediatrics, respiratory system, dermatology, as well as blood products, coagulation disorder treatment, and immune disease treatment. We own several renowned brands such as "999", "Dong-E-E-Jiao", "Double-Crane", "Jiangzhong", "Boya Bio", "Zizhu", "Kunzhong Medicine-1381", and "Nigale".
The company's business network covers 28 provinces, autonomous regions, and municipalities directly under the central government across China, with over 270,000 customers, providing highly professional and efficient supply chain services to upstream and downstream customers. In addition, we operate one of the largest retail pharmacy networks in China, with 708 retail pharmacies under our umbrella, of which the total number of DTP pharmacies reaches 270 (including 182 "dual-channel" pharmacies).
"Safeguarding human health and improving quality of life" is our noble mission. In the future, China Resources Pharmaceutical will seize the development and transformation opportunities in China's pharmaceutical and health industry, using R&D innovation and investment and M&A as engines, optimizing resource allocation, consolidating, strengthening, supplementing, and extending the industry chain to drive business development and industrial upgrading, continuously enhance core competitiveness, achieve high-quality development, and strive to become a leading innovative-driven pharmaceutical and health industry enterprise trusted by the public!
What does China Resources Pharmaceutical Commercial Group Co., Ltd. require? Who is China Resources Pharmaceutical Commercial hiring? China Resources Pharmaceutical Commercial recruitment: 销售类占比最多占46.7%,其次是计算机/网络/技术类占34%. What education can get in at China Resources Pharmaceutical Commercial? 本科占比最多占43.6%,其次是大专占36.7%. High education required at China Resources Pharmaceutical Commercial? 硕士占0.8%,博士占0.2%. Work experience required at China Resources Pharmaceutical Commercial? 不限占比最多占29.3%,其次是1-3年占28.5%. Where are the job locations at China Resources Pharmaceutical Commercial? 北京占比最多占42%,其次是成都占5.5%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows